New gum fix could spare patients from tissue grafts

NCT ID NCT06643507

Recruiting now Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat multiple receding gums using a substance made from the patient's own blood (Alb-PRF) compared to the standard connective tissue graft. 26 adults with good oral hygiene will be treated and followed to see how much gum coverage is achieved. The goal is to find a less invasive option that still works well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Albumin-platelet rich fibrin (Alb-PRF) and connective tissue graft (CTG)
What this could lead to: If it works, this could offer a less invasive, effective option for treating multiple gum recessions, potentially reducing the need for tissue grafts.
What could go wrong: This is a small, early-phase trial with only 26 people. The new method may not work better than the standard graft, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GINGIVAL RECESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gingival recession

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GINGIVAL RECESSION

Contacts and locations

Locations

Faculty of Dentistry Cairo University
RECRUITING

Cairo, 4240101, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.